The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products.

In this webinar, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences, Uppsala University, Sweden), will discuss:

• Population PK modelling to characterize drug exposure and variability
• PKPD-modelling to characterize preclinical time-kill data
• PKPD-modelling for translation to patients
• Model-based dose-individualization

The presentation will be followed by a Q&A session.

Speakers:

Lena Friberg and Elisabet Nielsen, Department of Pharmaceutical Biosciences, Uppsala University, Sweden

Moderator:

Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria

Register here for this live webinar.